Cargando…
Cytotoxin-associated gene-A-seropositivity and Interleukin-1 polymorphisms influence adverse cardiovascular events
AIMS: Although the bacterial virulent factor of cytotoxin-associated gene-A (CagA)-seropositivity and the host genetic factors of interleukin (IL)-1 polymorphisms have been suggested to influence Helicobacter pylori (HP) -related diseases, the underlying mechanisms of the association between HP infe...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062927/ https://www.ncbi.nlm.nih.gov/pubmed/32181324 http://dx.doi.org/10.1016/j.ijcha.2020.100498 |
_version_ | 1783504611105046528 |
---|---|
author | Tabata, Noriaki Sueta, Daisuke Arima, Yuichiro Okamoto, Ken Shono, Takashi Hanatani, Shinsuke Takashio, Seiji Oniki, Kentaro Saruwatari, Junji Sakamoto, Kenji Kaikita, Koichi Sinning, Jan-Malte Werner, Nikos Nickenig, Georg Sasaki, Yutaka Fukui, Toshihiro Tsujita, Kenichi |
author_facet | Tabata, Noriaki Sueta, Daisuke Arima, Yuichiro Okamoto, Ken Shono, Takashi Hanatani, Shinsuke Takashio, Seiji Oniki, Kentaro Saruwatari, Junji Sakamoto, Kenji Kaikita, Koichi Sinning, Jan-Malte Werner, Nikos Nickenig, Georg Sasaki, Yutaka Fukui, Toshihiro Tsujita, Kenichi |
author_sort | Tabata, Noriaki |
collection | PubMed |
description | AIMS: Although the bacterial virulent factor of cytotoxin-associated gene-A (CagA)-seropositivity and the host genetic factors of interleukin (IL)-1 polymorphisms have been suggested to influence Helicobacter pylori (HP) -related diseases, the underlying mechanisms of the association between HP infection and acute coronary syndrome (ACS) remain unknown. METHODS AND RESULTS: Among 341 consecutive ACS patients, the clinical outcomes after ACS included composite cardiovascular events within the 2-year follow-up period. A significantly higher probability of primary outcomes was observed in HP positive patients than in HP negative patients. There were no significant differences in the rate of cardiovascular events between HP positive and HP negative patients in the absence of an IL-polymorphism, while there were significant differences in the presence of an IL-polymorphism. There were significant differences in the rate of cardiovascular events among CagA positive, CagA negative/ HP positive and CagA negative/HP negative patients. Moreover, via immunohistochemical staining, aortic CagA positive cells were confirmed in the vasa vasorum in CagA positive patients, whereas they could not be identified in CagA negative patients. CONCLUSIONS: The bacterial virulence factor CagA and host genetic IL-1 polymorphisms influence the incidence of adverse cardiovascular events, possibly through infection of atherosclerotic lesions. Registration: University Hospital Medical Information Network (UMIN)-CTR (http://www.umin.ac.jp/ctr/). Identifier: UMIN000035696. |
format | Online Article Text |
id | pubmed-7062927 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-70629272020-03-16 Cytotoxin-associated gene-A-seropositivity and Interleukin-1 polymorphisms influence adverse cardiovascular events Tabata, Noriaki Sueta, Daisuke Arima, Yuichiro Okamoto, Ken Shono, Takashi Hanatani, Shinsuke Takashio, Seiji Oniki, Kentaro Saruwatari, Junji Sakamoto, Kenji Kaikita, Koichi Sinning, Jan-Malte Werner, Nikos Nickenig, Georg Sasaki, Yutaka Fukui, Toshihiro Tsujita, Kenichi Int J Cardiol Heart Vasc Original Paper AIMS: Although the bacterial virulent factor of cytotoxin-associated gene-A (CagA)-seropositivity and the host genetic factors of interleukin (IL)-1 polymorphisms have been suggested to influence Helicobacter pylori (HP) -related diseases, the underlying mechanisms of the association between HP infection and acute coronary syndrome (ACS) remain unknown. METHODS AND RESULTS: Among 341 consecutive ACS patients, the clinical outcomes after ACS included composite cardiovascular events within the 2-year follow-up period. A significantly higher probability of primary outcomes was observed in HP positive patients than in HP negative patients. There were no significant differences in the rate of cardiovascular events between HP positive and HP negative patients in the absence of an IL-polymorphism, while there were significant differences in the presence of an IL-polymorphism. There were significant differences in the rate of cardiovascular events among CagA positive, CagA negative/ HP positive and CagA negative/HP negative patients. Moreover, via immunohistochemical staining, aortic CagA positive cells were confirmed in the vasa vasorum in CagA positive patients, whereas they could not be identified in CagA negative patients. CONCLUSIONS: The bacterial virulence factor CagA and host genetic IL-1 polymorphisms influence the incidence of adverse cardiovascular events, possibly through infection of atherosclerotic lesions. Registration: University Hospital Medical Information Network (UMIN)-CTR (http://www.umin.ac.jp/ctr/). Identifier: UMIN000035696. Elsevier 2020-03-07 /pmc/articles/PMC7062927/ /pubmed/32181324 http://dx.doi.org/10.1016/j.ijcha.2020.100498 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Paper Tabata, Noriaki Sueta, Daisuke Arima, Yuichiro Okamoto, Ken Shono, Takashi Hanatani, Shinsuke Takashio, Seiji Oniki, Kentaro Saruwatari, Junji Sakamoto, Kenji Kaikita, Koichi Sinning, Jan-Malte Werner, Nikos Nickenig, Georg Sasaki, Yutaka Fukui, Toshihiro Tsujita, Kenichi Cytotoxin-associated gene-A-seropositivity and Interleukin-1 polymorphisms influence adverse cardiovascular events |
title | Cytotoxin-associated gene-A-seropositivity and Interleukin-1 polymorphisms influence adverse cardiovascular events |
title_full | Cytotoxin-associated gene-A-seropositivity and Interleukin-1 polymorphisms influence adverse cardiovascular events |
title_fullStr | Cytotoxin-associated gene-A-seropositivity and Interleukin-1 polymorphisms influence adverse cardiovascular events |
title_full_unstemmed | Cytotoxin-associated gene-A-seropositivity and Interleukin-1 polymorphisms influence adverse cardiovascular events |
title_short | Cytotoxin-associated gene-A-seropositivity and Interleukin-1 polymorphisms influence adverse cardiovascular events |
title_sort | cytotoxin-associated gene-a-seropositivity and interleukin-1 polymorphisms influence adverse cardiovascular events |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062927/ https://www.ncbi.nlm.nih.gov/pubmed/32181324 http://dx.doi.org/10.1016/j.ijcha.2020.100498 |
work_keys_str_mv | AT tabatanoriaki cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents AT suetadaisuke cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents AT arimayuichiro cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents AT okamotoken cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents AT shonotakashi cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents AT hanatanishinsuke cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents AT takashioseiji cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents AT onikikentaro cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents AT saruwatarijunji cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents AT sakamotokenji cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents AT kaikitakoichi cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents AT sinningjanmalte cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents AT wernernikos cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents AT nickeniggeorg cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents AT sasakiyutaka cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents AT fukuitoshihiro cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents AT tsujitakenichi cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents |